RARE vs SCOR · rev $350.0M vs P/E 1.3, rev $79.2M
Ultragenyx (RARE) versus Comscore Inc (SCOR) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Comscore Inc (SCOR) is a software - application company listed on NASDAQ.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
Latest reported SCOR revenue for 2026-06-30 was $79.2M. Net income was -$14.8M. Revenue was down 7.1% from 2026-03-31 to 2026-06-30. SCOR currently screens at market cap $109.4M and trailing P/E 1.3.
RARE currently screens at market cap $2.79B. SCOR currently screens at market cap $109.4M and trailing P/E 1.3.
Not investment advice. Open the RARE and SCOR stock pages for the full models.
Not investment advice.